Cargando…
Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19
COVID-19 disease has been identified to cause remarkable increase of mucormycosis infection cases in India, with the majority of cases being observed in individuals recovering from COVID-19. Mucormycosis has emanated as an outcome of the recent COVID-19 pandemic outbreak as rapidly developing fatal...
Autores principales: | Sharma, Neelam, Wani, Shahid Nazir, Behl, Tapan, Singh, Sukhbir, Zahoor, Ishrat, Sehgal, Aayush, Bhatia, Saurabh, Al-Harrasi, Ahmed, Aleya, Lotfi, Bungau, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713750/ https://www.ncbi.nlm.nih.gov/pubmed/36454526 http://dx.doi.org/10.1007/s11356-022-24032-2 |
Ejemplares similares
-
CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
por: Behl, Tapan, et al.
Publicado: (2022) -
Anticipated pharmacological role of Aviptadil on COVID-19
por: Mukherjee, Tuhin, et al.
Publicado: (2021) -
A motley of possible therapies of the COVID-19: reminiscing the origin of the pandemic
por: Kaur, Ishnoor, et al.
Publicado: (2022) -
Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D
por: Behl, Tapan, et al.
Publicado: (2021) -
Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies
por: Sharma, Neelam, et al.
Publicado: (2021)